Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Two lotions used day and night may be a good alternative to minoxidil for hair loss, with better cosmetic effects and tolerance.

Both new minoxidil formulations significantly stimulated hair growth and improved dermal metabolism.

Oral minoxidil has more side effects but can be more effective than topical minoxidil.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Low testosterone levels may contribute to female pattern hair loss in men.

2% minoxidil effectively increases hair count in women with androgenetic alopecia without severe side effects.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Calcium is crucial for sustaining root hair growth in Arabidopsis thaliana.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Apoptosis is essential for human skin development and forming a functional epidermis.

The document concludes that recent research has improved understanding of skin diseases and the balance between cell growth and differentiation in the epidermis.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Stem cell niches are essential for tissue health and repair.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Sebocytes play a key role in controlling androgen levels in human skin.